Asia-Pacific Americas Africa Europe Middle East

FERMION OY

Company Profile:

FERMION OY Company Introduction in Malaysia

Company Profile:

FERMION OY is a Finnish pharmaceutical company, a subsidiary of Orion Corporation. It specializes in the research, development, and manufacturing of Active Pharmaceutical Ingredients (APIs) for the global pharmaceutical industry. The company is recognized for its high-quality API production and adherence to stringent pharmaceutical standards.

Factory or Trader:

FERMION OY is primarily a manufacturer of Active Pharmaceutical Ingredients (APIs), with its main production facilities located in Finland. In Malaysia, FERMION OY does not operate a manufacturing factory. Its presence in Malaysia would typically involve sales, marketing, and distribution activities, functioning as a trader or supplier of its manufactured products to the Malaysian market.

Enterprise Products

Fermion Oy is a Finnish pharmaceutical company specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs). There is no "Malaysian Fermion Oy company" that produces or directly sells products in Malaysia. While Fermion Oy's APIs may be supplied to pharmaceutical manufacturers in Malaysia through global distribution channels, they do not have a production or direct sales presence as a Malaysian entity.

Fermion Oy manufactures a wide range of Active Pharmaceutical Ingredients (APIs) for various therapeutic areas. These include APIs for central nervous system disorders, cardiovascular diseases, oncology, and inflammatory conditions. Some examples of the specific APIs they produce are Carvedilol, Gabapentin, Pregabalin, Levetiracetam, Lacosamide, Ropinirole, Pramipexole, Tamsulosin, Donepezil, Rivastigmine, Galantamine, Memantine, Naltrexone, and Buprenorphine.

Business Registration Information:

Manager:

Arto Toivonen (President)

Phone:

+358 10 426 1234

E-mail:

info@fermion.fi

Official Website:
Address:

P.O. Box 425, FI-02101 Espoo, Finland

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.